Elodie Amour - IFCT, Paris, France | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 24 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

STK11/LKB1 Alterations Worsen the Poor Prognosis of KRAS Mutated Early-Stage Non-Squamous Non-Small Cell Lung Carcinoma, Results Based on the Phase 2 IFCT TASTE Trial

Jean Baptiste Oudart,Simon Garinet, Caroline Leger,Fabrice Barlesi,Gaelle Jeannin,Clarisse Audigier-Valette, Denis Morot-Sibilot,Alexandra Langlais,Elodie Amour,Nathalie Mathiot,Gary Birsen,Marie Wislez,Julien Mazi Eres

Lung Cancerpp.107508-107508, (2024)

Cited0Views0WOSBibtex

Adaptive Radiotherapy (up to 74 Gy) or Standard Radiotherapy (66 Gy) for Patients with Stage III Non-Small- Cell Lung Cancer, According to [18F]FDG-PET 18 F]FDG-PET Tumour Residual Uptake at 42 Gy (RTEP7-IFCT-1402): a Multicentre, Randomised, Controlled Phase 2 Trial

LANCET ONCOLOGYno. 9 (2024): 1176-1187

Cited0Views0Bibtex

1259MO Encorafenib Plus Binimetinib in Patients (pts) with Previously Untreated BRAF V600E-mutant Advanced Non-Small Cell Lung Cancer (NSCLC): an Open-Label, Multicenter Phase II Trial (IFCT-1904 ENCO-BRAF)

D. Planchard,J. Mazieres,C. Mascaux,F. Guisier,P. Tomasini,M. Wislez,D. Moro-Sibilot,S. Cousin,A.B. Cortot,S. Couraud,V. Fallet, C. Guguen, A. Lagrange,A-C. Madroszyk Flandin,J. Otto,M. Pérol,B. Roch,E. Amour,F. Morin,C. Ricordel

Annals of Oncology (2024): S806-S807

Cited0Views0Bibtex

A Phase II Randomized, Open-Labelled, Multicenter Study of Safety and Efficacy of Combination Brigatinib and Carboplatin-Pemetrexed Therapy or Brigatinib Monotherapy As First-Line Treatment in Patients with Advanced ALK-positive Non–small Cell Lung Cancer (IFCT-2101 MASTERPROTOCOL ALK)

Michael Duruisseaux,Aurelie Swalduz,Julien Mazieres,Fabrice Barlesi,Elodie Amour,Franck Morin,Virginie Westeel

Journal of Clinical Oncology（2022）

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn